Alexandria Real Estate Equities' Earnings Visibility Seen Limited, Morgan Stanley Says

MT Newswires Live01-10

Alexandria Real Estate Equities (ARE) faced limited visibility on its earnings trough amid an oversupply of life-science space and slowing demand from life-science tenants, Morgan Stanley said Friday in a report.

The firm initiated coverage of the stock with an equal-weight rating and a $55 price target.

Morgan Stanley expects a total return of about 9% with bullish and bearish prospects evenly balanced.

While the company's portfolio has outperformed the broader life science real estate market, sector headwinds have emerged with occupancy falling and same-store net operating income declining, the report said.

Management "reset expectations" at its 2025 investor day and expects same-store net operating income to fall 9% in 2026, the report said.

Funds from operations per share are forecast to decline 5% in 2025, 28% in 2026, and 9% in 2027, underperforming peers, Morgan Stanley said in its base case.

Upside prospects include better-than-expected execution on $2.9 billion in planned asset sales, increased funding for life science companies, and a stronger flight to quality in leasing, the report said.

Price: 53.34, Change: +0.07, Percent Change: +0.13

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment